Expert Review of Vaccines

Vaccine safety activists on the Internet
pp. 249-252(4)
Author: Wolfe, Robert M

News in Brief
pp. 253-256(4)

Cancer vaccines: is the future now?
pp. 257-260(4)
Authors: Weiner, David B; Kim, Joseph J

Progress in vaccination against cancer (PIVAC) 2002
pp. 261-263(3)
Authors: Li, Geng; Rees, Robert C

Needle-free epidermal powder immunization
pp. 265-276(12)
Authors: Chen, Dexiang; Maa, Yuh-Fun; Haynes, Joel R

Immunogenicity and reactogenicity of DTPw–HB/Hib vaccine administered to Colombian infants after a birth dose of hepatitis B vaccine
pp. 277-283(7)
Authors: López, Pio; Rubiano, Luisa; Rubio, Maria del Pilar; David, Marie-Pierre; Safary, Assad

T-cell vaccination for autoimmune diseases: immunologic lessons and clinical experience in multiple sclerosis
pp. 285-292(8)
Author: Zhang, Jingwu

Conditional live virus as a novel approach towards a safe live attenuated HIV vaccine
pp. 293-301(9)
Authors: Das, Atze T; Zhou, Xue; Vink, Monique; Klaver, Bep; Berkhout, Ben

Cellular vaccine therapy for cancer
pp. 303-316(14)
Authors: Armstrong, Anne C; Eaton, David; Ewing, Joanne C

Exoerythrocytic malaria vaccine development: understanding host–parasite immunobiology underscores strategic success
pp. 317-340(24)
Author: Taylor-Robinson, Andrew W

Tuberculosis vaccines: the past, present and future
pp. 341-354(14)
Authors: Wang, Jun; Xing, Zhou

Will the current measles vaccines ever eradicate measles?
pp. 355-362(8)
Author: Stephenson, John

Therapeutic vaccines for substance dependence
pp. 365-371(7)
Authors: Kosten, Thomas R; Biegel, Diane

Vaccines against hantaviruses
pp. 373-384(12)
Author: Hjelle, Brian

Development of oral microencapsulated forms for delivering viral vaccines
pp. 385-397(13)
Author: Nechaeva, Elena

Evolution of conjugate vaccines
pp. 399-410(12)
Authors: Mäkelä, P Helena; Käyhty, Helena